In tumour-bearing mice, MDSCs induce the emergence of a population of splenic PD1-PD-L1+CD19+IL-10-secreting B cells that inhibit effector T cell proliferation and IFNγ expression [39]. The gene discussed is CD19; the disease is neoplasm.